X-78657726-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152694.3(RTL3):āc.695A>Cā(p.Glu232Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,209,011 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152694.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000720 AC: 8AN: 111099Hom.: 0 Cov.: 22 AF XY: 0.000150 AC XY: 5AN XY: 33291
GnomAD3 exomes AF: 0.000110 AC: 20AN: 181650Hom.: 0 AF XY: 0.0000905 AC XY: 6AN XY: 66270
GnomAD4 exome AF: 0.0000455 AC: 50AN: 1097862Hom.: 0 Cov.: 31 AF XY: 0.0000468 AC XY: 17AN XY: 363238
GnomAD4 genome AF: 0.0000630 AC: 7AN: 111149Hom.: 0 Cov.: 22 AF XY: 0.000120 AC XY: 4AN XY: 33351
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.695A>C (p.E232A) alteration is located in exon 2 (coding exon 1) of the ZCCHC5 gene. This alteration results from a A to C substitution at nucleotide position 695, causing the glutamic acid (E) at amino acid position 232 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at